RxDoctor Payments Data
★ My doctorsLook up a doctor →

Patrick Dauphin, MD

Interventional Cardiology · Hattiesburg, MSNPI 1962866004

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $8,103 of the $9,120 with a category attached, or 88.9%. It is spread thinly across 35 manufacturers, the largest accounting for just 14.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $3,235 and has fallen 84.9% since, to $488 in 2025.

$9,120in general payments, 2019–2025

Across 204 payments — averaging $44.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$1K
  • Abiomed$1K
  • AstraZeneca$864
  • Boston Scientific$662
  • Boehringer Ingelheim$645
  • Penumbra, Inc.$575
  • plus $4K from 29 others

What the payments were for

  • Travel & lodging$1,01711%
  • Food & beverage$8,10389%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic13$1,362
Abiomed16$1,108
AstraZeneca14$864
Boston Scientific9$662
Boehringer Ingelheim14$645
Penumbra, Inc.5$575
Inari Medical, Inc.10$479
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)6$428
Pfizer28$424
Philips North America LLC4$311
Novartis16$270
Johnson & Johnson13$212
Shockwave Medical, Inc3$206
Abbott2$184
E.r. Squibb & Sons, L.L.C.12$179
Livanova USA, Inc.2$153
Acist Medical Systems, Inc.1$149
Cvrx, Inc.1$146
Amgen9$133
Lantheus Medical Imaging, Inc.2$131
Scpharmaceuticals Inc.2$106
Actelion Pharmaceuticals US, Inc.3$64
Irhythm Technologies, Inc.3$48
Astellas Pharma US Inc2$43
Imperative Care, Inc2$38
Chiesi USA, Inc.2$31
Akcea Therapeutics, Inc.2$29
Cardiva Medical, Inc.1$25
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC1$23
Biosense Webster, Inc.1$19
Stryker1$16
GE HealthCare1$16
Cardiovascular Systems Inc.1$15
Edwards Lifesciences1$14
Merck1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,120 in reported general payments places this provider in the 55th percentile of 65 interventional cardiology providers in Mississippi.

See all interventional cardiology providers in Mississippi →

Medicare billing

Part B allowed, 2024
$91,791
Medicare patients
208
Services billed
660

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate70$750
Atorvastatin Calcium33$312
Metoprolol Succinate24$296
Rosuvastatin Calcium45$277
Isosorbide Mononitrate ErIsosorbide Mononitrate25$153
Carvedilol13$58
Pantoprazole Sodium19$32
Amlodipine Besylate16$29

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Hattiesburg

See the full list for Mississippi →

Where these figures come from

Is this you, or does something look wrong? →